177 related articles for article (PubMed ID: 22377532)
1. Cell density-dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells.
Spassieva SD; Rahmaniyan M; Bielawski J; Clarke CJ; Kraveka JM; Obeid LM
J Lipid Res; 2012 May; 53(5):918-928. PubMed ID: 22377532
[TBL] [Abstract][Full Text] [Related]
2. Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells.
Kraveka JM; Li L; Szulc ZM; Bielawski J; Ogretmen B; Hannun YA; Obeid LM; Bielawska A
J Biol Chem; 2007 Jun; 282(23):16718-28. PubMed ID: 17283068
[TBL] [Abstract][Full Text] [Related]
3. C22:0- and C24:0-dihydroceramides confer mixed cytotoxicity in T-cell acute lymphoblastic leukemia cell lines.
Holliday MW; Cox SB; Kang MH; Maurer BJ
PLoS One; 2013; 8(9):e74768. PubMed ID: 24040340
[TBL] [Abstract][Full Text] [Related]
4. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.
Fabrias G; Muñoz-Olaya J; Cingolani F; Signorelli P; Casas J; Gagliostro V; Ghidoni R
Prog Lipid Res; 2012 Apr; 51(2):82-94. PubMed ID: 22200621
[TBL] [Abstract][Full Text] [Related]
5. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
Jang Y; Rao X; Jiang Q
J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081
[TBL] [Abstract][Full Text] [Related]
6. Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.
Breen P; Joseph N; Thompson K; Kraveka JM; Gudz TI; Li L; Rahmaniyan M; Bielawski J; Pierce JS; VAN Buren E; Bhatti G; Separovic D
Anticancer Res; 2013 Jan; 33(1):77-84. PubMed ID: 23267130
[TBL] [Abstract][Full Text] [Related]
7. Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity.
Rodriguez-Cuenca S; Barbarroja N; Vidal-Puig A
Biochim Biophys Acta; 2015 Jan; 1851(1):40-50. PubMed ID: 25283058
[TBL] [Abstract][Full Text] [Related]
8. Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms.
Casasampere M; Ordóñez YF; Casas J; Fabrias G
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):264-275. PubMed ID: 27894925
[TBL] [Abstract][Full Text] [Related]
9. Dihydroceramide delays cell cycle G1/S transition via activation of ER stress and induction of autophagy.
Gagliostro V; Casas J; Caretti A; Abad JL; Tagliavacca L; Ghidoni R; Fabrias G; Signorelli P
Int J Biochem Cell Biol; 2012 Dec; 44(12):2135-43. PubMed ID: 22960157
[TBL] [Abstract][Full Text] [Related]
10. [Recent advances in study of dihydroceramide].
Li FF; Zhang D; Bao XQ; Sun H
Yao Xue Xue Bao; 2016 Sep; 51(9):1388-93. PubMed ID: 29924512
[TBL] [Abstract][Full Text] [Related]
11. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide.
Michel C; van Echten-Deckert G; Rother J; Sandhoff K; Wang E; Merrill AH
J Biol Chem; 1997 Sep; 272(36):22432-7. PubMed ID: 9312549
[TBL] [Abstract][Full Text] [Related]
12. Ablation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitro.
Siddique MM; Bikman BT; Wang L; Ying L; Reinhardt E; Shui G; Wenk MR; Summers SA
PLoS One; 2012; 7(9):e44042. PubMed ID: 22984457
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of short-chain ceramide and dihydroceramide analogues in Chinese hamster ovary (CHO) cells.
Ridgway ND; Merriam DL
Biochim Biophys Acta; 1995 Apr; 1256(1):57-70. PubMed ID: 7742357
[TBL] [Abstract][Full Text] [Related]
14. Loss of function and reduced levels of sphingolipid desaturase DEGS1 variants are both relevant in disease mechanism.
Dei Cas M; Montavoci L; Pasini C; Caretti A; Penati S; Martinelli C; Gianelli U; Casati S; Nardecchia F; Torella A; Brunetti-Pierri N; Trinchera M
J Lipid Res; 2024 Mar; 65(3):100517. PubMed ID: 38342436
[TBL] [Abstract][Full Text] [Related]
15. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
[TBL] [Abstract][Full Text] [Related]
16. Dihydroceramide desaturase activity is modulated by oxidative stress.
Idkowiak-Baldys J; Apraiz A; Li L; Rahmaniyan M; Clarke CJ; Kraveka JM; Asumendi A; Hannun YA
Biochem J; 2010 Mar; 427(2):265-74. PubMed ID: 20105137
[TBL] [Abstract][Full Text] [Related]
17. Conversion of dihydroceramide into ceramide: involvement of a desaturase.
Geeraert L; Mannaerts GP; van Veldhoven PP
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):125-32. PubMed ID: 9355743
[TBL] [Abstract][Full Text] [Related]
18. Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells.
Signorelli P; Munoz-Olaya JM; Gagliostro V; Casas J; Ghidoni R; Fabriàs G
Cancer Lett; 2009 Sep; 282(2):238-43. PubMed ID: 19394759
[TBL] [Abstract][Full Text] [Related]
19. Lipophagy prevents activity-dependent neurodegeneration due to dihydroceramide accumulation
Jung WH; Liu CC; Yu YL; Chang YC; Lien WY; Chao HC; Huang SY; Kuo CH; Ho HC; Chan CC
EMBO Rep; 2017 Jul; 18(7):1150-1165. PubMed ID: 28507162
[TBL] [Abstract][Full Text] [Related]
20. Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling.
Siddique MM; Li Y; Wang L; Ching J; Mal M; Ilkayeva O; Wu YJ; Bay BH; Summers SA
Mol Cell Biol; 2013 Jun; 33(11):2353-69. PubMed ID: 23547262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
